Home
AMPAC Analytical

AMPAC Analytical Market Share Analysis for May 2026

Learn more about our history and capabilities as a trusted CDMO partner for companies across the drug development and manufacturing spectrum.

Industry: N/A

Domainampacanalytical.com

Year Founded2016

Employees51 - 200

Annual Revenue--

AMPAC Analytical

AMPAC Analytical (including company regionals)

ampacanalytical.com

See more website traffic and engagement information

Total visits to AMPAC Analytical's top domains

Understand AMPAC Analytical market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in AMPAC Analytical's top domains

Analyze AMPAC Analytical engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on AMPAC Analytical's top domains

See how AMPAC Analytical keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

AMPAC Analytical top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by AMPAC Analytical

These are the website technologies, by industry, used by AMPAC Analytical top domains

Widget (6)

Twemoji

Advertising (4)

DoubleClick

Conversion & Analytics (3)

Google Analytics

Audio Video Media (2)

Vimeo

More Technologies

7

See all

News & Signals from AMPAC Analytical

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsAmpacanalytical invested into assets: facility in the amount of $25M in Petersburg, Virginia, United States, Northern America, Americas on May 4th '21.And then on May 4, AMPAC Fine Chemicals, a leading manufacturer of Active Pharmaceutical Ingredients (APIs) in the United States, announced it will invest $25 million to expand its facility in Petersburg, creating 156 new jobs.

NewsAmpacanalytical partners with Phlow Corporation.AMPAC Fine Chemicals is a major collaborator in the new U.S. government-funded partnership with Phlow Corporation, Medicines for All Institute, and non-profit drugmaker Civica Inc.